Ascend Wellness Seeks Shareholder Approval for 1-for-10 to 1-for-50 Reverse Stock Split for Potential Up-listing
AAWH sits 72% above its 52-week low of $0.26 on light trading volume (0.1× avg).
Summary
Ascend Wellness Holdings is asking shareholders to approve a reverse stock split, ranging from 1-for-10 to 1-for-50, to boost its share price for a potential listing on a major exchange.
Key Events · Corporate Governance and Compliance · AAWH
-
Reverse Stock Split Proposed
Shareholders will vote on a reverse stock split with a ratio between 1-for-10 and 1-for-50, to be determined by the Board, at a special meeting on August 28, 2026.
-
Goal: Exchange Up-listing
The primary objective is to increase the share price to meet minimum bid requirements for a potential listing on NYSE American or Nasdaq, moving from the OTCQX.
-
Significant Dilution Potential
The authorized share count remains unchanged, which, after the reverse split, will result in a large pool of authorized but unissued shares. If all authorized shares were issued, dilution would be 269.3%.
-
Federal Cannabis Law Hurdle
The company highlights that current federal laws and exchange policies regarding adult-use cannabis operations present a major obstacle to listing on national securities exchanges.
Analysis · AAWH · Life Sciences
The company is seeking shareholder approval for a reverse stock split, ranging from 1-for-10 to 1-for-50, primarily to increase its share price to meet minimum bid requirements for a potential up-listing to the NYSE American or Nasdaq. While up-listing could broaden the investor base, the reverse split itself is a reactive measure to a low stock price, especially given recent financial declines. A significant concern is that the number of authorized shares will not be reduced, meaning the post-split company will have a much larger pool of authorized but unissued shares (if all authorized shares were issued, dilution would be 269.3%), creating a substantial overhang and potential for future dilution. Furthermore, the company acknowledges that current federal cannabis laws and exchange policies pose a significant hurdle to listing on national exchanges, even with a higher share price.
How filings like this one have moved
In the 30 days to Oct 4, 2026, 29.2% of the 1581 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.60%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AAWH was trading at $0.45 on OTC in the Life Sciences sector, with a market capitalization of approximately $90.8M. The 52-week trading range was $0.26 to $1.20. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.